![Thomas Civik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Civik
Chief Executive Officer at
PYXIS ONCOLOGY, INC.
Net worth: 516 994 $ as of 30/09/2026
Profile
Thomas Civik is Chairman & Chief Executive Officer at Pyxis Oncology, Inc. since 2026.
Formerly, Mr. Civik was President, Chief Executive Officer & Director at Five Prime Therapeutics, Inc. from 2020 to 2021.
Mr. Civik served as Independent Chairman at Repare Therapeutics, Inc. from 2021 to 2026 and at Imcheck Therapeutics SAS. Mr. Civik was Vice President-Avastin Sales & Marketing at Genentech, Inc. from 2000 to 2017.
Mr. Civik was Chief Commercial Officer at Foundation Medicine, Inc. from 2017 to 2019.
Education includes undergraduate studies at St. Norbert College, Inc. and an MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PYXIS ONCOLOGY, INC. 0.27% | 04/09/2026 | 221,886 ( 0.27% ) | 516 994 $ | 30/09/2026 |
Thomas Civik active positions
| Companies | Position | Start |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Chief Executive Officer | 03/02/2026 |
Former positions of Thomas Civik
| Companies | Position | End |
|---|---|---|
| REPARE THERAPEUTICS INC. | Chairman | 28/01/2026 |
| FIVE PRIME THERAPEUTICS, INC. | Chief Executive Officer | 16/04/2021 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01/09/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Sales & Marketing | 01/11/2017 |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Chairman | - |
Education of Thomas Civik
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
St. Norbert College, Inc.
 St. Norbert College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer therapies | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
- Stock Market
- Insiders
- Thomas Civik
